Medical Devices

Amecath Medical Technologies is the leading Egyptian catheter manufacturer. Amecath has a fast growing export business, based on a value-product-approach.

 

Investment Rationale

Growth capital investment into a small but profitable manufacturer of vascular access, dialysis and urology catheters.

Investment date September 2012
Exit date —
Sector Medical Devices
Region HQ Egypt, exporting globally
Investment type Growth

Business Highlights and Impact

  • Established in Egypt in 1991, Amecath is the leading catheter manufacturing company in Egypt (market share of 65%).
  • Applies stringent corporate governance system, including Board of Directors. Improved financial reporting and planning system, clear delegation of authority matrix, and ESG framework
  • Appointed Robert Mitchell, former President of Endologix, as Chairman of the Board
  • Deployed internal task force to support senior management with reorganization and growth plan execution as an international player
  • Implemented new ERP solution
  • Supported automation
  • Continuous improvement of product quality
  • The company has emerged as an exporter of vascular access, dialysis and urology catheters.
  • Amecath holds several patents and FDA approved products
  • Manufacturing cost very competitive against Asian competition
  • In the wake of the global Covid-19 crisis, Amecath served the growing the demand for high-quality products in its field of expertise.
  • Overall: improved quality, a streamlined product program and export markets, with measurable improvement of export strategy, export share and team additions.